Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

20 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

ChroPac-trial: duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis - start

- 06.02.23 - 7 Formulare, 11 Itemgruppen, 40 Datenelemente, 1 Sprache
Itemgruppen: Date of Visit, Inclusion Criteria, Exclusion Criteria, Quality of Life, Demography, Clinical Data, Duration of Symptoms, Imaging Techniques, Results preop imaging, Results preop Endoscopy, ERCP
Duodenum-preserving head resection versus pancreatico-duodenectomy for chronic pancreatitis of the head. Study Center of the German Surgical Society (SDGC) Trial protocol of a randomised controlled multicentre trial. Trials. 2010 Apr 29;11:47. doi: 10.1186/1745-6215-11-47. PMID: 20429912; PMCID: PMC2874785. Controlled-trials.com ISRCTN38973832

start

9 Itemgruppen 14 Datenelemente

start

6 Itemgruppen 15 Datenelemente

start

6 Itemgruppen 19 Datenelemente

start

6 Itemgruppen 14 Datenelemente

start

6 Itemgruppen 14 Datenelemente

start

5 Itemgruppen 11 Datenelemente

Pre-Study - PRIOR SURGERY SUPPLEMENT - 2398212v1.0 - PRIOR SURGERY SUPPLEMENT

- 20.09.21 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: PRIOR SURGERY SUPPLEMENT, COMMENTS
Prior Surgery form for C3D 3.12 Adopters Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF2F7B22-5065-707B-E034-0003BA3F9857

Eligibility Major Surgery NCT00655980

- 13.06.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Vitamins in Nitrous Oxide Study; ODM derived from: https://clinicaltrials.gov/show/NCT00655980

Eligibility Eversion in Dermatologic Surgery NCT01770002

- 22.09.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?; ODM derived from: https://clinicaltrials.gov/show/NCT01770002 Sponsor: University of California, Davis Information provided by (Responsible Party): University of California, Davis Principal Investigator: Daniel Eisen, M.D. University of California, Davis

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - Radiotherapy; Local Surgery (Report Final and Annex Report 2 Final)

- 30.10.20 - 1 Formular, 5 Itemgruppen, 17 Datenelemente, 1 Sprache
Itemgruppen: Administrative, Radiotherapy, Radiotherapy , Local Surgery, Local Surgery
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

Subcutaneous fondaparinux sodium for prevention of venous thromboembolic events; Study ID: 104619 - Visit 01

- 22.10.18 - 1 Formular, 9 Itemgruppen, 69 Datenelemente, 1 Sprache
Itemgruppen: Operative Surgical Procedures; Details, Hematology finding, Inclusion, Exclusion Criteria, Inclusion, Exclusion Criteria, Therapeutic procedure, Assignment, Exclusion Criteria, Therapeutic Procedures, Assignment
Study ID: 104619 Clinical Study ID: 63129 Study Title:A multinational, randomized, double-blind comparison of once daily subcutaneous fondaparinux sodium with placebo for the prevention of venous thromboembolic events in acutely ill medical patients (ARTEMIS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thrombosis, Venous

Eligibility Of Bypass Graft of the Extremities NCT02492854

- 02.06.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Standard Versus PICO Dressings in Lower-Extremity Bypass Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02492854

Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling NCT00937833 - Eligibility

- 17.04.19 - 1 Formular, 2 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
The purpose of this study is to determine the impact of an absorbable urethrovesical sling on the post-operative return of urinary continence after robot-assisted radical prostatectomy. ODM derived from: https://clinicaltrials.gov/show/NCT00937833

Eligibility Liver Transplantation NCT01139203

- 30.06.20 - 1 Formular, 2 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT01139203

Eligibility Kidney Transplant NCT00659620

- 12.05.18 - 1 Formular, 2 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy; ODM derived from: https://clinicaltrials.gov/show/NCT00659620

Eligibility Kidney Transplant NCT00296296

- 12.04.17 - 1 Formular, 3 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Inclusion Criteria, Exclusion Criteria
Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM); ODM derived from: https://clinicaltrials.gov/show/NCT00296296

Eligibility Complication of Transplanted Liver NCT00867243

- 15.02.17 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Prediction of Hepatitis C Recurrence in Liver Transplant Recipients; ODM derived from: https://clinicaltrials.gov/show/NCT00867243

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video